Search Share Prices

AZN Shares - A Note On AstraZeneca PLC's (LON:AZN) ROE and Debt To Equity

To keep the lesson grounded in practicality, we'll use ROE to better understand AstraZeneca PLC (LON:AZN). AstraZeneca has a ROE of 14%, based on the last twelve months. That means that for every £1 ...

Read More »

AstraZeneca and Merck’s Lynparza drug approved by US FDA for pancreatic cancer

“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...

Read More »

Will these 3 FTSE 100 shares make 20% gains in 2020? Barclays, Taylor Wimpey and AstraZeneca

The performances of FTSE 100 shares Barclays PLC (LON:BARC) (BARC.L), Taylor Wimpey plc (LON:TW) (TW.L) and AstraZeneca plc (LON:AZN) (AZN.L) in 2019 has been strong. All three stocks have made gains ...

Read More »

AstraZeneca and Daiichi Sankyo's breast cancer treatment gets US approval

AstraZeneca and Daiichi Sankyo are exploring the further potential of Enhertu in HER2-breast cancer with three ongoing Phase III trials The US Food and Drug Administration (FDA) has approved Enhertu, ...

Read More »

AstraZeneca’s (AZN) Overweight Rating Reiterated at Barclays

Barclays restated their overweight rating on shares of AstraZeneca (LON:AZN) in a research report report published on Friday morning, ThisIsMoney.Co.Uk reports. Several other equities research ...

Read More »

Related Share Prices